連環(huán)蛋白β1(β-catenin)單克隆抗體
Monoclonal Antibody to Beta Catenin (β-catenin)
CTNNb1; bCat; b-Cat; CTNN-B1; Catenin Beta 1; Cadherin-Associated Protein
- 編號MAB021Hu27
 - 物種Homo sapiens (Human,人)相同的名稱,不同的物種。
 - 來源單抗制備
 - 宿主小鼠
 - 效價(克隆號)C7
 - Ig亞型 IgG2b Kappa
 - 純化方式蛋白A + 蛋白G親和純化
 - 標(biāo)記物無標(biāo)記物
 - 免疫原RPB021Hu01-連環(huán)蛋白β1(β-catenin)重組蛋白
 - 緩沖液成份磷酸鹽緩沖液(pH7.4)
 - 性狀液體
 - 濃度1mg/mL
 - 且適物種Mus musculus (Mouse,小鼠), Rattus norvegicus (Rat,大鼠), Cavia (Guinea pig ,豚鼠), Canis familiaris; Canine (Dog,犬), Sus scrofa; Porcine (Pig,豬), Bos taurus; Bovine (Cattle,牛), Chicken (Gallus,雞)
 - 應(yīng)用WB; IHC
如果抗體需用于流式細(xì)胞術(shù),請參見流式抗體。 - 下載英文說明書 中文說明書
 - 規(guī)格20μl100μl200μl1ml10ml
 - 價格¥ 778¥ 1814¥ 2592¥ 6480¥ 25920
 - 欲了解實際交易價格和更多情況,請與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
 
特異性
該抗體是針對β-catenin的小鼠單克隆抗體。在免疫組織化學(xué)染色和免疫印跡實驗中能識別β-catenin。
用法
Western blotting: 0.01-2μg/mL;
Immunohistochemistry: 5-20μg/mL;
Immunocytochemistry: 5-20μg/mL;
Optimal working dilutions must be determined by end user.
儲存
經(jīng)常使用則4°C保存。-20°C保存不超過兩年。避免反復(fù)凍融。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定,具體方法如下:在37°C孵育48小時,沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當(dāng)?shù)臈l件下存儲,損失率低于5%。
贈品
增值服務(wù)
相關(guān)產(chǎn)品
| 編號 | 適用物種:Homo sapiens (Human,人) | 應(yīng)用(僅供研究使用,不用于臨床診斷!) | 
| RPB021Hu01 | 連環(huán)蛋白β1(β-catenin)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. | 
| RPB021Hu02 | 連環(huán)蛋白β1(β-catenin)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. | 
| PAB021Hu01 | 連環(huán)蛋白β1(β-catenin)多克隆抗體 | WB; IHC | 
| CAB021Hu01 | 抗連環(huán)蛋白β1(β-catenin)多克隆抗體 | WB; IHC | 
| MAB021Hu23 | 連環(huán)蛋白β1(β-catenin)單克隆抗體 | WB; IHC | 
| MAB021Hu24 | 連環(huán)蛋白β1(β-catenin)單克隆抗體 | WB; IHC | 
| MAB021Hu25 | 連環(huán)蛋白β1(β-catenin)單克隆抗體 | WB; IHC | 
| MAB021Hu27 | 連環(huán)蛋白β1(β-catenin)單克隆抗體 | WB; IHC | 
| MAB021Hu21 | 連環(huán)蛋白β1(β-catenin)單克隆抗體 | WB; IHC | 
| MAB021Hu22 | 連環(huán)蛋白β1(β-catenin)單克隆抗體 | WB; IHC | 
| MAB021Hu26 | 連環(huán)蛋白β1(β-catenin)單克隆抗體 | WB | 
| CAB021Hu22 | 抗連環(huán)蛋白β1(β-catenin)單克隆抗體 | WB; IHC | 
| MAB021Hu29 | 連環(huán)蛋白β1(β-catenin)單克隆抗體 | WB | 
| SEB021Hu | 連環(huán)蛋白β1(β-catenin)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. | 
| LMB021Hu | 連環(huán)蛋白β1(β-catenin)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. | 
| KSB021Hu01 | 連環(huán)蛋白β1(β-catenin)檢測試劑盒DIY材料(酶聯(lián)免疫吸附試驗法) | 自己動手制作ELISA試劑盒的主要材料 | 
參考文獻(xiàn)
| 雜志 | 參考文獻(xiàn) | 
| Clinica Chimica Acta | Versican and its associated molecules: Potential diagnostic markers for multiple myeloma[Pubmed:25623955] | 
| Journal of Bone and Mineral Research | Adverse effects of osteocytic constitutive activation of ?-catenin on bone strength and bone growth[Pubmed:25639729] | 
| Am J Transl Res | Role of SDF-1 and Wnt signaling pathway in the myocardial fibrosis of hypertensive rats[PubMed: 26396666] | 
| Scientific Reports | Is there an association between enhanced choline and β-catenin pathway in breast cancer? A pilot study by MR Spectroscopy and ELISA.[pubmed:28533512] | 
| Life Sciences | Hepatoprotective effect of hesperidin in hepatocellular carcinoma: Involvement of Wnt signaling pathways.[pubmed:28754618] | 
| Scientific Reports | Is there an association between enhanced choline and β-catenin pathway in breast cancer? A pilot study by MR Spectroscopy and ELISA[Pubmed: 28533512] | 
| The Showa University Journal of Medical Sciences | Eribulin Treatment Induces High Expression of miR-195 and Inactivates the Wnt/β-catenin Signaling Pathway in Triple-negative Breast Cancer[Doi: 10.15369/sujms.30.359] | 
| Advances in?Medical?Sciences | Urinary procollagen III aminoterminal propeptide and β-catenin–New diagnostic biomarkers in solitary functioning kidney?[Pubmed: 30738287] | 
| Biomed Pharmacother | Silence of FAM83H-AS1 promotes chemosensitivity of gastric cancer through Wnt/β-catenin signaling pathway[Pubmed: 32028241] | 
| Journal of Cosmetic Dermatology | Novel complex of cosmetic ingredients with promising action in preventing hair loss and follicular aging through mechanism involving enrichment of WNT/signaling?…[Pubmed: 33179848] | 
| Nutrients | Hydroxytyrosol as a Promising Ally in the Treatment of Fibromyalgia[Pubmed: 32784915] | 
| Oncotarget | Amalgamation of PI3K and EZH2 blockade synergistically regulates invasion and angiogenesis: combination therapy for glioblastoma multiforme[33473259] | 
| Cytokine | QNZ alleviated hepatocellular carcinoma by targeting inflammatory pathways in a rat model[34564023] | 






